Lobe Sciences appoints COO

gustavofrazao
- Biopharmaceutical company Lobe Sciences (OTCQB:LOBEF) said on Wednesday that Baxter Phillips III has been appointed to the newly created position of COO, effective immediately.
- The position was created to provide additional executive leadership.
- Additionally, Phillips has also been appointed as president of the unit, Altemia and Company.
- Phillips will report to chairman and CEO Philip Young.
- Phillips has been associated with Lobe Sciences as a board member since October 2022.
- Source: Press Release